Company / Accounts Receivable
Vericel Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$84.6M
FY2025
5-year range
$37.4M / $84.6M
FY2021-FY2025
Trend
+37.9%
vs FY2024
Sector context
#60 of 113
Health Care
What the data says
At $85M, Vericel's accounts receivable ranks #60 of 113 in the Health Care sector. Accounts Receivable has increased for 9 consecutive years, from $17M in FY2016 to $85M in FY2025.
Based on SEC 10-K filings.
$85M in FY2025 with a 5-year CAGR of +19.7%.
Improved from $58M to $85M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +22.1%
- 5-Year CAGR
- +19.7%
- 10-Year CAGR
- -
Sector benchmark
#60 of 113 in Health CareTop 53% of 113This company $84.6M Sector average $1.1B
▼
-92.6% below sector average
Key checks
Key Insights
- Vericel's accounts receivable has grown for 9 consecutive years.
- 5-year CAGR of +19.7%, indicating consistent growth.
- In FY2025, accounts receivable increased 37.9% year-over-year.
- Ranks #60 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $84.6M | +37.9% |
| FY2024 | $61.4M | +5.2% |
| FY2023 | $58.4M | +25.4% |
| FY2022 | $46.5M | +24.3% |
| FY2021 | $37.4M | +8.5% |
| FY2020 | $34.5M | +7.3% |
| FY2019 | $32.2M | +37.2% |
| FY2018 | $23.5M | +28.4% |
| FY2017 | $18.3M | +6.9% |
| FY2016 | $17.1M | +56.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026